Breast Cancer Tests

Genomic Testing

Genomic tests look at your specific tumor’s genes, to help find out what’s driving its growth. Using gene expression testing to help design a tailored treatment plan is called personalized medicine.  These are not the same as genetic tests that determine your inherited risk or hereditary predisposition for cancer.
Your physician will assess many factors prior to determining your treatment plan, including the size of the tumor, lymph node involvement, and the hormone receptor status of your cancer.

These factors, along with your tumor’s genomic profile, can help you and your physician make the most informed treatment decisions for your specific type of cancer.

Adam Brufsky, M.D.

Dr. Adam Brufsky discusses a study comparing MammaPrint® to the 21-gene assay and how BluePrint® molecular subtyping compares to traditional subtyping.

Massimo Cristofanilli, M.D.

Dr. Massimo Cristofanilli discusses the benefits of using the MammaPrint® 70-Gene assay and the BluePrint® 80-Gene assay in the treatment process for breast cancer.

Rene Bernards, Ph.D.

Dr. Rene Bernards discusses how breast cancer biology inspired the development of MammaPrint®.

We work with Doctors and their Patients

I am a Doctor


I am a Patient